Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359818 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359741 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359798 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359801 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359750 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359746 (US9822103, Example 17 | t-Butyl 4-(5-(5-(((4,6-dim...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359837 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359845 (2-Isopropyl-7-(6-(4-isopropylpiperazin-1-yl)pyridi...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359846 (2-Methyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359839 (2-Methyl-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropy...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359809 (US9822103, Example 69 | rac-(3aS,8bS)-5-Bromo-N-((...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359747 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359730 (7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359756 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359840 (2-isopropyl-2-methyl-N-((6-methyl-2-oxo-4-propyl-1...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359740 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359805 (US9822103, Example 65 | rac-(3aS,8bS)—N-((4,6-Dime...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <500 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359808 (US9822103, Example 68 | rac-(3aS,8bS)—N-((4,6-Dime...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359736 (7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359755 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359806 (US9822103, Example 66 | rac-(3aS,8bS)—N-((4,6-Dime...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359743 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359807 (US9822103, Example 67 | rac-(3aS,8bS)—N-((4,6-Dime...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359834 (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 750 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359735 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359754 (7-Bromo-2,2-dimethyl-N-((6-methyl-2-oxo-4-propyl-1...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359768 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359771 ((2S,3R)-7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydro...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359810 (7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359811 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359820 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359826 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359836 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359843 (8-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359733 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359738 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359739 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359742 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359758 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359763 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359764 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359765 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359793 (N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359822 (7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359838 (9-Bromo-3,4-dimethyl-N-((6-methyl-2-oxo-4-propyl-1...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359749 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359751 (7-Benzyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359730 (7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359753 (7-Chloro-2,2-dimethyl-N-((6-methyl-2-oxo-4-propyl-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359759 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359761 (7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359767 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359797 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359803 (US9822103, Example 64 | rac-(3aS,8bS)-5-Bromo-N-((...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359784 (9-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359790 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359825 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359841 (9-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359737 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359757 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359760 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359766 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359769 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359795 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359734 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359772 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359773 (8-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359775 (9-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359777 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359799 (US9822103, Example 60 | t-Butyl 4-(5-(5-(((4,6-dim...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359797 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359831 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359833 (7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359842 (8-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359731 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359776 (9-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359780 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359785 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359791 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359792 (9-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359796 (7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359819 (US9822103, Example 73 | tert-Butyl 4-(5-(5-(((4,6-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359844 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359732 (7-Chloro-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359744 ((E)-N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359745 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359762 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359774 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359779 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359794 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359800 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359824 (N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)met...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359827 (7-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human)) | BDBM359832 (9-Bromo-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description EZH2 Histone Methyl Transferase Assay: The effectiveness of compounds of the present invention as inhibitors of histone methyl transferases can be r... | US Patent US9822103 (2017) BindingDB Entry DOI: 10.7270/Q29W0HSW | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
